NCT04165317 A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04163419 Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04156672 Real World Study Of The Clinical Profile And Treatment Outcomes Of Advanced Therapies For Ulcerative Colitis In Portugal Status WITHDRAWN Phase N/A
NCT04155541 Special Investigation for VIZIMPRO Tablets (Secondary Data Collection Study; Safety and Efficacy of VIZIMPRO Under Japanese Medical Practice) Status COMPLETED Phase N/A
NCT04152018 Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. Status TERMINATED Phase PHASE1
NCT04148209 Study of Single Ascending Doses of PF-07081532 in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT04135560 A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants Status COMPLETED Phase PHASE1
NCT04134884 Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT04134715 A Drug Drug Interaction Study Between PF-06826647 And Oral Contraceptive Steroids In Healthy Female Participants Status COMPLETED Phase PHASE1
NCT04130152 Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy Status COMPLETED Phase EARLY_PHASE1
NCT04126486 A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke Status COMPLETED Phase PHASE4
NCT04126330 Effect of Omega-3 and Probiotic Dietary Supplements on Elevated High Sensitivity C-reactive Protein (Hs-CRP) as a Marker of Low-grade Inflammation Status COMPLETED Phase NA
NCT04126135 Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy Status COMPLETED Phase PHASE4
NCT04126044 A SINGLE-DOSE, 2-ARM, PHARMACOKINETIC STUDY OF PF-06439535 (CN) AND EUROPEAN UNION SOURCED BEVACIZUMAB IN CHINESE HEALTHY MALE VOLUNTEERS Status WITHDRAWN Phase PHASE1
NCT04126031 Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants. Status TERMINATED Phase PHASE2
NCT04124653 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants Status COMPLETED Phase PHASE1
NCT04115189 A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA) Status COMPLETED Phase N/A
NCT04111614 A Study to Demonstrate the Equivalence of the Tofacitinib Oral Solution to the Tablet Formulation in Healthy Participants. Status COMPLETED Phase PHASE1